BANK VONTOBEL/CALL/MEDTRONIC/85/0.1/20.06.25 Share Price

Warrant

DE000VD49D83

Market Closed - Börse Stuttgart 11:47:45 14/06/2024 am IST
0.58 EUR -1.69% Intraday chart for BANK VONTOBEL/CALL/MEDTRONIC/85/0.1/20.06.25
Current month+7.41%
1 month-23.68%
Date Price Change
14/24/14 0.58 -1.69%
13/24/13 0.59 -3.28%
12/24/12 0.61 -10.29%
11/24/11 0.68 -4.23%
10/24/10 0.71 +16.39%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 11:47 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Vontobel Vontobel
WKN VD49D8
ISINDE000VD49D83
Date issued 29/04/2024
Strike 85 $
Maturity 20/06/2025 (369 Days)
Parity 10 : 1
Emission price 0.64
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.9
Lowest since issue 0.54
Delta0.47x
Omega 6.468
Premium12.22x
Gearing13.64x
Moneyness 0.9534
Difference Strike 3.96 $
Difference Strike %+4.66%
Spread 0.01
Spread %1.79%
Theoretical value 0.5550
Implied Volatility 22.20 %
Total Loss Probability 59.86 %
Intrinsic value 0.000000
Present value 0.5550
Break even 90.94 €
Theta-0.01x
Vega0.03x
Rho0.03x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
81.04 USD
Average target price
94.07 USD
Spread / Average Target
+16.08%
Consensus